Immunomodulatory effect of mushrooms and their bioactive compounds in cancer: A comprehensive review DOI Open Access
Manash Pratim Pathak, Kalyani Pathak, Riya Saikia

и другие.

Biomedicine & Pharmacotherapy, Год журнала: 2022, Номер 149, С. 112901 - 112901

Опубликована: Апрель 4, 2022

Despite enormous development in the field of drug development, cancer still remains elusive. Compromised immunity stands as a roadblock to successful pharmacological execution anti-cancer drugs used clinically currently. Recently some breakthrough treatment strategy like nano-formulation, extracellular vesicles treatment, natural antioxidant therapy, targeted immunotherapy, gene thermal ablation and magnetic hyperthermia, pathomics radiomics has been developed tested pre-clinically well clinically. However, clinical efficacy such therapies is yet establish are too costly be utilized by patients from poor developing countries. At this juncture, researchers heading towards search medicines sources that higher safety margin multitarget compared conventional treatments. Mushroom traditionally food since time immemorial due its immunomodulatory effect which loaded with proteins, low fat content cholesterol. Mushrooms recommended one best vegetarian diets for immunosuppressed HIV/AIDS patients. well-known their activity impacts hematopoietic stem cells, lymphocytes, macrophages, T dendritic cells (DCs), killer (NK) immune system. This comprehensive review article emphasizes on molecular mechanisms genesis, therapy reported significant selected species mushrooms bioactive phytoconstituents followed brief discussion recent metallic nanoparticles mushrooms.

Язык: Английский

Reactive Oxygen Species (ROS)-Based Nanomedicine DOI
Bowen Yang, Yu Chen, Jianlin Shi

и другие.

Chemical Reviews, Год журнала: 2019, Номер 119(8), С. 4881 - 4985

Опубликована: Апрель 11, 2019

Reactive oxygen species (ROS) play an essential role in regulating various physiological functions of living organisms. The intrinsic biochemical properties ROS, which underlie the mechanisms necessary for growth, fitness, or aging organisms, have been driving researchers to take full advantage these active chemical contributing medical advances. Thanks remarkable advances nanotechnology, great varieties nanomaterials with unique ROS-regulating explored guide temporospatial dynamic behaviors ROS biological milieu, contributes emergence a new-generation therapeutic methodology, i.e., nanomaterial-guided vivo evolution therapy. interdependent relationship between and their corresponding chemistry, biology, nanotherapy leads us propose concept "ROS science", is believed be emerging scientific discipline that studies mechanisms, effects, nanotherapeutic applications ROS. In this review, state-of-art concerning recent progresses on ROS-based nanotherapies summarized detail, emphasis underlying material chemistry by are generated scavenged improved outcomes. Furthermore, key issues cross-disciplinary fields also discussed, aiming unlock innate powers optimized efficacies. We expect our demonstration evolving field will beneficial further development fundamental researches clinical applications.

Язык: Английский

Процитировано

2018

Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players DOI Creative Commons
Xiaotian Yuan, Catharina Larsson, Dawei Xu

и другие.

Oncogene, Год журнала: 2019, Номер 38(34), С. 6172 - 6183

Опубликована: Июль 8, 2019

Abstract Long-lived species Homo sapiens have evolved robust protection mechanisms against cancer by repressing telomerase and maintaining short telomeres, thereby delaying the onset of majority types until post-reproductive age. Indeed, is silent in most differentiated human cells, predominantly due to transcriptional repression its catalytic component reverse transcriptase (TERT) gene. The lack telomerase/TERT expression leads progressive telomere erosion dividing whereas critically shortened length induces a permanent growth arrest stage named replicative senescence. TERT/telomerase activation has been experimentally shown be essential cellular immortalization malignant transformation stabilizing erasing senescence barrier. Consistently, TERT expression/telomerase activity detectable up 90% primary cancers. Compelling evidence also accumulated that contributes development progression via multiple activities beyond canonical telomere-lengthening function. Given these key roles oncogenesis, great efforts made decipher underlying induction. In last two decades since gene promoter were cloned, derepression achieved typically at level through dysregulation oncogenic factors or signaling, post-transcriptional/translational regulation genomic amplification. However, advances high-throughput next-generation sequencing technologies prompted revolution genomics, which recent discovery alterations take center activating this review article, we summarize critical transcription, with special emphases on contribution mutations structural locus, briefly discuss implications events-driven hyperactivity initiation/progression potential clinical applications as well.

Язык: Английский

Процитировано

362

Clinical Development of Metal Complexes as Photosensitizers for Photodynamic Therapy of Cancer DOI
Johannes Karges

Angewandte Chemie International Edition, Год журнала: 2021, Номер 61(5)

Опубликована: Ноя. 8, 2021

Cancer has emerged over the last decades as one of deadliest diseases in world. Among most commonly used techniques (i.e. surgery, immunotherapy, radiotherapy or chemotherapy), increasing attention been devoted towards photodynamic therapy. However, vast majority clinically applied photosensitizers are not ideal and associated with several limitations including poor aqueous solubility, photostability slow clearance from body, causing photosensitivity. In an effort to overcome these drawbacks, much incorporation a metal ion. Herein, clinical development metal-containing compounds Purlytin

Язык: Английский

Процитировано

306

The role of retrotransposable elements in ageing and age-associated diseases DOI
Vera Gorbunova, Andrei Seluanov, Paolo Mita

и другие.

Nature, Год журнала: 2021, Номер 596(7870), С. 43 - 53

Опубликована: Авг. 4, 2021

Язык: Английский

Процитировано

290

Regulation of cGAS- and RLR-mediated immunity to nucleic acids DOI
Andrea Ablasser, Sun Hur

Nature Immunology, Год журнала: 2019, Номер 21(1), С. 17 - 29

Опубликована: Дек. 9, 2019

Язык: Английский

Процитировано

277

Biomaterials and engineered microenvironments to control YAP/TAZ-dependent cell behaviour DOI
Giovanna Brusatin, Tito Panciera, Alessandro Gandin

и другие.

Nature Materials, Год журнала: 2018, Номер 17(12), С. 1063 - 1075

Опубликована: Окт. 23, 2018

Язык: Английский

Процитировано

237

The Genetics of Aging: A Vertebrate Perspective DOI Creative Commons
Param Priya Singh, Brittany A. Demmitt, Ravi D. Nath

и другие.

Cell, Год журнала: 2019, Номер 177(1), С. 200 - 220

Опубликована: Март 1, 2019

Язык: Английский

Процитировано

235

The influence of evolutionary history on human health and disease DOI Open Access
Mary Lauren Benton, Abin Abraham, Abigail L. LaBella

и другие.

Nature Reviews Genetics, Год журнала: 2021, Номер 22(5), С. 269 - 283

Опубликована: Янв. 6, 2021

Язык: Английский

Процитировано

221

Cancer and Aging: Two Tightly Interconnected Biological Processes DOI Open Access
Lieze Berben, Giuseppe Floris, Hans Wildiers

и другие.

Cancers, Год журнала: 2021, Номер 13(6), С. 1400 - 1400

Опубликована: Март 19, 2021

Age is one of the main risk factors cancer; several biological changes linked with aging process can explain this. As our population progressively aging, proportion older patients cancer increasing significantly. Due to heterogeneity general health and functional status amongst persons, treatment a major challenge in this vulnerable population. Older often experience more side effects anticancer treatments. Over-treatment should be avoided ensure an optimal quality life. On other hand, under-treatment due fear toxicity frequent problem lead increased relapse worse survival. There delicate balance between benefits therapy toxicity. Robust biomarkers that reflect body’s age may aid outlining individual regimens for cancer. In particular, impact on systemic immunity tumor immune infiltrate considered, given expanding role immunotherapy treatment. review, we summarize current knowledge concerning mechanistic connections cancer, as well could helpful field geriatric oncology.

Язык: Английский

Процитировано

169

Cancer risk across mammals DOI Creative Commons
Orsolya Vincze, Fernando Colchero,

Jean-François Lemaître

и другие.

Nature, Год журнала: 2021, Номер 601(7892), С. 263 - 267

Опубликована: Дек. 22, 2021

Abstract Cancer is a ubiquitous disease of metazoans, predicted to disproportionately affect larger, long-lived organisms owing their greater number cell divisions, and thus increased probability somatic mutations 1,2 . While elevated cancer risk with larger body size and/or longevity has been documented within species 3–5 , Peto’s paradox indicates the apparent lack such an association among taxa 6 Yet, unequivocal empirical evidence for lacking, stemming from difficulty estimating in non-model species. Here we build analyse database on cancer-related mortality using data adult zoo mammals (110,148 individuals, 191 species) map age-controlled mammalian tree life. We demonstrate universality high frequency oncogenic phenomena reveal substantial differences across major orders. show that phylogenetic distribution associated diet, carnivorous (especially mammal-consuming ones) facing highest mortality. Moreover, provide components by showing largely independent both mass life expectancy These results highlight key role life-history evolution shaping resistance advancements quest natural anticancer defences.

Язык: Английский

Процитировано

167